Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils

Molecular and Biochemical Parasitology

Volumn 166, Issue 2, 2009, Pages 159-171

  Adda, Christopher G ^a   Murphy, Vince J ^a   Sunde, Margaret ^b   Waddington, Lynne J ^c   Schloegel, Jesse ^a   Talbo, Gert H ^a   Vingas, Kleo ^a   Kienzle, Vivian ^a   Masciantonio, Rosella ^a   Howlett, Geoffrey J ^d   Hodder, Anthony N ^e   Foley, Michael ^a   Anders, Robin F ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Amyloid; Intrinsically unstructured protein; Malaria; MSP2; Vaccine

Indexed keywords

AMYLOID; CONGO RED; GLUTARALDEHYDE; MEROZOITE SURFACE PROTEIN 2; MONOCLONAL ANTIBODY; MONOMER; OLIGOMER; PEPTIDE; PROTEINASE K; THIOFLAVINE;

AMINO TERMINAL SEQUENCE; ANTIGEN ANTIBODY REACTION; ARTICLE; BETA SHEET; CONTROLLED STUDY; CROSS LINKING; ERYTHROCYTE; FIBER; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN STRUCTURE; STAIN;

AMINO ACID SEQUENCE; AMYLOID; ANIMALS; ANTIGENS, PROTOZOAN; HUMANS; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 65549120208     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2009.03.012     Document Type: Article

References (80)

1. Richie T.L., and Saul A. Progress and challenges for malaria vaccines. Nature 415 (2002) 694-701
2. Ling I.T., Ogun S.A., and Holder A.A. Immunization against malaria with a recombinant protein. Parasite Immunol 16 (1994) 63-67
3. Anders R.F., Crewther P.E., Edwards S., et al. Immunization with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16 (1998) 240-247
4. Hodder A.N., Crewther P.E., and Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun 69 (2001) 3286-3294
5. Stowers A.W., Cioce V., Shimp R.L., et al. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial. Infect Immun 69 (2001) 1536-1546
6. Malkin E.M., Diemert D.J., McArthur J.H., et al. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun 73 (2005) 3677-3685
7. Kocken C.H., Withers-Martinez C., Dubbeld M.A., et al. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun 70 (2002) 4471-4476
8. Angov E., Aufiero B.M., Turgeon A.M., et al. Development and pre-clinical analysis of a Plasmodium falciparum merozoite surface protein-1(42) malaria vaccine. Mol Biochem Parasitol 128 (2003) 195-204
9. Saul A., Lawrence G., Allworth A., et al. A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant. Vaccine 23 (2005) 3076-3083
10. Genton B., Betuela I., Felger I., et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 185 (2002) 820-827
11. Gerold P., Schofield L., Blackman M.J., Holder A.A., and Schwarz R.T. Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. Mol Biochem Parasitol 75 (1996) 131-143
12. Smythe J.A., Coppel R.L., Day K.P., et al. Structural diversity in the Plasmodium falciparum merozoite surface antigen 2. Proc Natl Acad Sci USA 88 (1991) 1751-1755
13. Fenton B., Clark J.T., Khan C.M., et al. Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol Cell Biol 11 (1991) 963-971
14. Thomas A.W., Carr D.A., Carter J.M., and Lyon J.A. Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2. Mol Biochem Parasitol 43 (1990) 211-220
15. Smythe J.A., Peterson M.G., Coppel R.L., Saul A.J., Kemp D.J., and Anders R.F. Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum. Mol Biochem Parasitol 39 (1990) 227-234
16. Dyson H.J., and Wright P.E. Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 12 (2002) 54-60
17. Dyson H.J., and Wright P.E. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6 (2005) 197-208
18. Tompa P. Intrinsically unstructured proteins. Trends Biochem Sci 27 (2002) 527-533
19. Tompa P. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett 579 (2005) 3346-3354
20. Uversky V.N. Natively unfolded proteins: a point where biology waits for physics. Protein Sci 11 (2002) 739-756
21. Romero P., Obradovic Z., Kissinger C.R., et al. Thousands of proteins likely to have long disordered regions. Pac Symp Biocomput (1998) 437-448
22. Dunker A.K., Obradovic Z., Romero P., Garner E.C., and Brown C.J. Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform 11 (2000) 161-171
23. Feng Z.-P., Zhang X., Han P., Arora N., Anders R.F., and Norton R.S. Abundance of intrinsically unstructured proteins in P. falciparum and other apicomplexan parasite proteomes. Mol Biochem Parasitol 150 (2006) 256-267
24. Mohan A., Sullivan Jr. W.J., Radivojac P., Dunker A.K., and Uversky V.N. Intrinsic disorder in pathogenic and non-pathogenic microbes: discovering and analyzing the unfoldomes of early-branching eukaryotes. Mol Biosyst 4 (2008) 328-340
25. Kemp D.J., Coppel R.L., and Anders R.F. Repetitive proteins and genes of malaria. Annu Rev Microbiol 41 (1987) 181-208
26. Zhang X., Perugini M.A., Yao S., et al. Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2. J Mol Biol 379 (2008) 105-121
27. Trager W., and Jensen J.B. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
28. Dluzewski A.R., Rangachari K., Wilson R.J., and Gratzer W.B. Relation of red cell membrane properties to invasion by Plasmodium falciparum. Parasitology 91 Pt 2 (1985) 273-280
29. Saul A., Lawrence G., Smillie A., et al. Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant. Vaccine 17 (1999) 3145-3159
30. Baskakov I.V., Legname G., Baldwin M.A., Prusiner S.B., and Cohen F.E. Pathway complexity of prion protein assembly into amyloid. J Biol Chem 277 (2002) 21140-21148
31. Wijaya R., Neumann G.M., Condron R., Hughes A.B., and Polya G.M. Defense proteins from seed of Cassia fistula include a lipid transfer protein homologue and a protease inhibitory plant defensin. Plant Sci 159 (2000) 243-255
32. Hardouin J. Protein sequence information by matrix-assisted laser desorption/ionization in-source decay mass spectrometry. Mass Spectrom Rev 26 (2007) 672-682
33. Wang L., Lashuel H.A., Walz T., and Colon W. Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proc Natl Acad Sci USA 99 (2002) 15947-15952
34. Hatters D.M., MacRaild C.A., Daniels R., et al. The circularization of amyloid fibrils formed by apolipoprotein C-II. Biophys J 85 (2003) 3979-3990
35. Ellis J., Ozaki L.S., Gwadz R.W., et al. Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature 302 (1983) 536-538
36. Dame J.B., Williams J.L., McCutchan T.F., et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225 (1984) 593-599
37. Saint R.B., Coppel R.L., Cowman A.F., et al. Changes in repeat number, sequence, and reading frame in S-antigen genes of Plasmodium falciparum. Mol Cell Biol 7 (1987) 2968-2973
38. Anders R.F., Brown G.V., and Edwards A. Characterization of an S antigen synthesized by several isolates of Plasmodium falciparum. Proc Natl Acad Sci USA 80 (1983) 6652-6656
39. Baxa U., Taylor K.L., Wall J.S., et al. Architecture of Ure2p prion filaments: the N-terminal domains form a central core fiber. J Biol Chem 278 (2003) 43717-43727
40. Bakthisaran R., Ban T., Sakai M., et al. αβ-crystallin, a small heat shock protein, prevents the amyloid fibril growth of an amyloid β-peptide and β2-microglobulin. Biochem J (2005) 2005
41. Kim Y.S., Randolph T.W., Stevens F.J., and Carpenter J.F. Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein. Insights into transition states from pressure, temperature, and co-solute studies. J Biol Chem 277 (2002) 27240-27246
42. Ohnishi S., Koide A., and Koide S. The roles of turn formation and cross-strand interactions in fibrillization of peptides derived from the OspA single-layer β-sheet. Protein Sci 10 (2001) 2083-2092
43. Saul A., Lord R., Jones G., Geysen H.M., Gale J., and Mollard R. Cross-reactivity of antibody against an epitope of the Plasmodium falciparum second merozoite surface antigen. Parasite Immunol 11 (1989) 593-601
44. Coppel R.L., Cowman A.F., Lingelbach K.R., et al. Isolate-specific S-antigen of Plasmodium falciparum contains a repeated sequence of eleven amino acids. Nature 306 (1983) 751-756
45. Romero P., Obradovic Z., and Dunker A.K. Natively disordered proteins: functions and predictions. Appl Bioinform 3 (2004) 105-113
46. Linding R., Russell R.B., Neduva V., and Gibson T.J. GlobPlot: Exploring protein sequences for globularity and disorder. Nucleic Acids Res 31 (2003) 3701-3708
47. Linding R., Jensen L.J., Diella F., Bork P., Gibson T.J., and Russell R.B. Protein disorder prediction: implications for structural proteomics. Structure (Camb) 11 (2003) 1453-1459
48. Bourhis J.M., Receveur-Brechot V., Oglesbee M., et al. The intrinsically disordered C-terminal domain of the measles virus nucleoprotein interacts with the C-terminal domain of the phosphoprotein via two distinct sites and remains predominantly unfolded. Protein Sci 14 (2005) 1975-1992
49. Csizmok V., Bokor M., Banki P., et al. Primary contact sites in intrinsically unstructured proteins: the case of calpastatin and microtubule-associated protein 2. Biochemistry 44 (2005) 3955-3964
50. Jonker H.R., Wechselberger R.W., Boelens R., Folkers G.E., and Kaptein R. Structural properties of the promiscuous VP16 activation domain. Biochemistry 44 (2005) 827-839
51. Verkhivker G.M. Protein conformational transitions coupled to binding in molecular recognition of unstructured proteins: deciphering the effect of intermolecular interactions on computational structure prediction of the p27Kip1 protein bound to the cyclin A-cyclin-dependent kinase 2 complex. Proteins 58 (2005) 706-716
52. Pachebat J.A., Ling I.T., Grainger M., et al. The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7. Mol Biochem Parasitol 117 (2001) 83-89
53. Trucco C., Fernandez-Reyes D., Howell S., et al. The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. Mol Biochem Parasitol 112 (2001) 91-101
54. Alexander D.L., Arastu-Kapur S., Dubremetz J.-F., and Boothroyd J.C. Plasmodium falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a component of the moving junction in Toxoplasma gondii. Eukaryot Cell 5 (2006) 1169-1173
55. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., and Blake C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 273 (1997) 729-739
56. Miake H., Mizusawa H., Iwatsubo T., and Hasegawa M. Biochemical characterization of the core structure of α-synuclein filaments. J Biol Chem 277 (2002) 19213-19219
57. Selvaggini C., De Gioia L., Cantu L., et al. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Res Commun 194 (1993) 1380-1386
58. Low A., Chandrashekaran I.R., Adda C.G., et al. Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain. Biopolymers 87 (2007) 12-22
59. Uversky V.N. A protein-chameleon: conformational plasticity of α-synuclein, a disordered protein involved in neurodegenerative disorders. J Biomol Struct Dyn 21 (2003) 211-234
60. Ratnaswamy G., Koepf E., Bekele H., Yin H., and Kelly J.W. The amyloidogenicity of gelsolin is controlled by proteolysis and pH. Chem Biol 6 (1999) 293-304
61. Viles J.H., Donne D., Kroon G., et al. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics. Biochemistry 40 (2001) 2743-2753
62. Yang X., Adda C.G., Keizer D.W., et al. A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils. J Pept Sci 13 (2007) 839-848
63. Kriwacki R.W., Hengst L., Tennant L., Reed S.I., and Wright P.E. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc Natl Acad Sci USA 93 (1996) 11504-11509
64. Penkett C.J., Redfield C., Jones J.A., et al. Structural and dynamical characterization of a biologically active unfolded fibronectin-binding protein from Staphylococcus aureus. Biochemistry 37 (1998) 17054-17067
65. Butikofer P., Malherbe T., Boschung M., and Roditi I. GPI-anchored proteins: now you see'em, now you don't. FASEB J 15 (2001) 545-548
66. Miettinen-Baumann A., Strych W., McBride J., and Heidrich H.G. A 46,000 dalton Plasmodium falciparum merozoite surface glycoprotein not related to the 185,000-195,000 dalton schizont precursor molecule: isolation and characterization. Parasitol Res 74 (1988) 317-323
67. Wang L., Mohandas N., Thomas A., and Coppel R.L. Detection of detergent-resistant membranes in asexual blood-stage parasites of Plasmodium falciparum. Mol Biochem Parasitol 130 (2003) 149-153
68. Dobson C.M. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15 (2004) 3-16
69. Kelly J.W., and Balch W.E. Amyloid as a natural product. J Cell Biol 161 (2003) 461-462
70. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75 (2006) 333-366
71. Wickner R.B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264 (1994) 566-569
72. Uptain S.M., and Lindquist S. Prions as protein-based genetic elements. Annu Rev Microbiol 56 (2002) 703-741
73. Tuite M.F., and Cox B.S. Propagation of yeast prions. Nat Rev Mol Cell Biol 4 (2003) 878-890
74. Gebbink M.F., Claessen D., Bouma B., Dijkhuizen L., and Wosten H.A. Amyloids-a functional coat for microorganisms. Nat Rev Microbiol 3 (2005) 333-341
75. Chapman M.R., Robinson L.S., Pinkner J.S., et al. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295 (2002) 851-855
76. Claessen D., Rink R., de Jong W., et al. A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils. Genes Dev 17 (2003) 1714-1726
77. Wosten H.A., and de Vocht M.L. Hydrophobins, the fungal coat unravelled. Biochim Biophys Acta 1469 (2000) 79-86
78. Mackay J.P., Matthews J.M., Winefield R.D., Mackay L.G., Haverkamp R.G., and Templeton M.D. The hydrophobin EAS is largely unstructured in solution and functions by forming amyloid-like structures. Structure (Camb) 9 (2001) 83-91
79. Jayakumar R., Kusiak J.W., Chrest F.J., et al. Red cell perturbations by amyloid β-protein. Biochim Biophys Acta 1622 (2003) 20-28
80. Murali J., Koteeswari D., Rifkind J.M., and Jayakumar R. Amyloid insulin interaction with erythrocytes. Biochem Cell Biol 81 (2003) 51-59